Amicus Therapeutics
Price & Volume
Stats
See more52W Range | $5.51-$14.48 |
Market Cap | $4.5B |
Shares Short | 21M |
Financials
See moreRevenue (12 Mos) | $634.2M |
Revenue Growth (YoY) | 23.7% |
Gross Profit (12 Mos) | $561.2M |
Diluted EPS | -$0.09 |
News
See moreYahoo Finance • last month
Investment Manager Bets Big on PTCT Stock, Adds 41,000 Shares, According to Recent SEC Filing
Yahoo Finance • last month
Investment Firm Adds Nearly $4 Milllion Worth of DYN Shares, According to Recent SEC Filing
Yahoo Finance • last month
Catalyst Watch: Jobs report, new Apple products, and a spotlight on software
Yahoo Finance • 2 months ago
Amicus Therapeutics Non-GAAP EPS of $0.31, revenue of $634M
About
CEO | Mr. Bradley L. Campbell M.B.A. |
Address | 47 Hulfish Street, Princeton, NJ, United States, 08542 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 511 |
